Dr. Batsides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CVP Cardiac Surgery, The Heart and Vascular Hospital
30 Prospect Avenue 1 Link
Hackensack, NJ 07601Phone+1 551-996-1333Fax+1 551-996-0949
Summary
- Dr. George Batsides is a thoracic surgeon in Hackensack, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Hackensack University Medical Center and Hackensack Meridian Health Hackensack University Medical Center. He received his medical degree from St. George's University School of Medicine and has been in practice 20 years. He specializes in adult cardiac surgery, aortic surgery, minimally invasive cardiac surgery, and cardiovascular surgery and is experienced in transcatheter valve surgery, adult general thoracic surgery, aortic surgery, minimally invasive cardiac surgery, and minimally invasive thoracic surgery.
Education & Training
- Rutgers Robert Wood Johnson Medical SchoolFellowship, Thoracic Surgery, 2002 - 2005
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 1997 - 2002
- St. George's University School of MedicineClass of 1997
- Villanova UniversityBA, 1986 - 1990
Certifications & Licensure
- NJ State Medical License 2000 - 2025
- SC State Medical License 2003 - 2004
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Bergen County’s Top Doctors Bergen Magazine, 2020
- FACC American College of Cardiology
- New Jersey Top Doctor New Jersey Monthly Magazine, 2014-2018
- Join now to see all
Publications & Presentations
PubMed
- Multiple Valvular Heart Disease in the Transcatheter Era: A State-of-the-Art Review.Craig Basman, David Landers, Yuriy Dudiy, Sung-Han Yoon, George Batsides
Structural Heart. 2024-07-01 - 35 citationsEarly Outcomes of the First 200 US Patients Treated with Impella 5.5: A Novel Temporary Left Ventricular Assist Device.Danny Ramzy, Mark E. Anderson, George Batsides, Masahiro Ono, Scott C. Silvestry
Innovations. 2021-06-08 - 3 citationsQuadricuspid Aortic Valve: A Rare Cause of Aortic Regurgitation.Analise Douglas, Ankitkumar Patel, George Batsides, Lucy Safi
CASE. 2020-05-15
Journal Articles
- Original Article Early Outcomes of the First 200 US Patients Treated with Impella 5.5: A Novel Temporary Left Ventricular Assist DeviceDanny Ramzy1, MD, PhD , Mark Anderson2, MD, George Batsides2, MD, Masahiro Ono3, MD, Scott Silvestry4, MD, David A. D’Alessandro5, MD, Masaki Funamoto5, MD, PhD, Eli..., Inovations, 6/8/2021
Abstracts/Posters
- Minimally Invasive Reoperative Surgery is the Preferred Approach after Previous SternotomyAnthony Lemaire MD, FACS, Madonna Lee MD, George Batsides MD, Aziz Ghaly MD, and Leonard Y. Lee MD., ISMICS 2016 Annual Meeting, Montreal, CA, 6/16/2016
- Effect Of Body Mass Index (BMI) On Outcomes In Cardiac Valve SurgerySiavash Saadat, Karan Chhabra, Viktor Dombrovskiy, Anthony Lemaire, Aziz Ghaly, George Batsides, Leonard Y. Lee., The Heart Valve Society, New York, NY, 3/17/2016
Lectures
- Circulatory Support In Cardiogenic ShockOMICS 4th International Conference on Clinical & Experimental Cardiology - 4/14/2014
- Circulatory Support in Acute Cardiogenic Shock: A Bridge to Decision, A Bridge to Recovery62nd ANNUAL CLINICAL SYMPOSIUM NEW JERSEY CHAPTER, AMERICAN COLLEGE OF SURGEONS DECEMBER 14, 2013 - 12/14/2013
Other
- Primary Cardiac Angiosarcoma Presenting as a Rapidly Growing Right Atrial MassVatsal Bhatta, MSIII, Joseph Ibrahima, MSII, Christopher Maulionb, MD, George Batsidesb, MD, Pratik Patelb, MD, Cath Lab Digest
https://www.cathlabdigest.com/article/Primary-Cardiac-Angiosarcoma-Presenting-Rapidly-Growing-Right-Atrial-Mass
Cathlabdigest.com - 7/2017
Authored Content
- Early outcomes of the first 200 US patients treated with impella 5.5: a novel temporary ventricular assist deviceJune 2021
Press Mentions
- Heart Care Close to HomeJanuary 25th, 2021
- Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic ShockFebruary 13th, 2018
- Robert Wood Johnson – MEDICINE 1April 8th, 2017
- Join now to see all
Professional Memberships
- International Society of Heart & Lung TransplantationMember
- Member
- Member
Industry Relationships
- Speaker, Abiomed Inc
- Advisory Board, Abiomed Inc.
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: